Latest filing published 02 Jan 2014 for Albireo Pharma, INC., €18k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ira Lieberman: trading record in brief
This profile gathers the share dealings of Ira Lieberman in Albireo Pharma, Inc. Between 17 May 2007 and 20 December 2013, the trades on record add up to 4 filings.
Market trades split into 1 purchase (€18k) and 1 sale (€256k). Netting one side against the other leaves €238k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 option exercise. In 2014 alone, the filings show 1 purchase and no sales.
The record was last updated on 2 January 2014 with an open-market purchase (€18k) in Albireo Pharma, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ira Lieberman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,800 shares@ US$2.29Common StockSEC:0001145443-14-000005:0Canonical exit: 20 Mar 2014 (T+90)
- 1,969 sharesCommon StockSEC:0001466049-11-000092:0
- 21,535 shares@ US$17.50Common StockSEC:0001209191-07-067667:0
- 17,710 shares0Common StockSEC:0000910680-07-000441:0
4 of 4 declarations
